Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

about

Centrally Acting Agents for Obesity: Past, Present, and Future Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release

P2860

Q57177981-066ABCDE-4A67-4FFD-B2AE-56F3F9417493 Q58764917-5D405E52-1E47-480E-B123-06AE36E3ADD4

P2860

Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

Item

http://www.wikidata.org/entity/Q39182453

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@en

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@nl

type

Item

label

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@en

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@nl

prefLabel

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@en

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@nl

P1476

Combination Varenicline and Lo ...... Obese Smokers: A Pilot Study.

@en

P2093

Darrell R Schroeder

http://www.w3.org/2001/XMLSchema#string

Doo-Sup Choi

http://www.w3.org/2001/XMLSchema#string

Ivana T Croghan

http://www.w3.org/2001/XMLSchema#string

J Taylor Hays

http://www.w3.org/2001/XMLSchema#string

Jon O Ebbert

http://www.w3.org/2001/XMLSchema#string

Ryan T Hurt

http://www.w3.org/2001/XMLSchema#string

P2860

The Influence of Smoking Cessation on the Prevalence of Overweight in the United States

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

Multicenter, placebo-controlled trial of lorcaserin for weight management.

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.

Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control

Estimating the effect of smoking cessation on weight gain: an instrumental variable approach.

Tobacco dependence counseling in a randomized multisite clinical trial

Weight gain in smokers after quitting cigarettes: meta-analysis.

P31

scholarly article

P356

10.1093/NTR/NTW304

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27852796

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

weight gain

P932

6251525

http://www.w3.org/2001/XMLSchema#string

Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

about

P2860

P2860

Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P932